IINO Shiro

イイノシロウ | IINO Shiro

Affiliation and department：
Job title： Senior Assistant Professor
Research theme for competitive and other funds (1)：

Papers (23)：

Hasegawa T, Iino S, Fujisaki M, Okamura S, Baba N, Tanaka N, Takeuchi Y, Oyama N, Hasegawa M. Two cases of acute-onset cystoid macular edema and serous retinal detachment associated with combined use of encorafenib and binimetinib for advanced melanoma: A possible confounding risk for drug intolerance. J Cutan. Immunol Allergy. 2023. 2023;00:1-3
Sekine S, Iino S, Nishimura K, Okamura S, Kasamatsu H, Oyama N, Hirai K, Hasegawa M. A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full-thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine. J Cutan Immunol Allergy . 2023. 6. 2. 63-65
Uesugi-Uchida S, Fujisaki M, Sekine S, Chino T, Oyama N, Hasegawa M. Non-episodic angioedema with eosinophilia developing after influenza vaccination. J Dermatol. 2023. 50. 3. e96-e97
Hasegawa T, Oyama N, Kasamatsu H, Chino T, Taga M, Hasegawa M. Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption. J Dermatol. 2022. 49. 12. e453-e454
A.Tsuji, K.Hiramatsu, S.Namikawa, A.Yamamoto, Y.Midori, Y.Murata, T.Tanaka, T.Nosaka, T.Naito, K.Takahashi, et al. A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma. CLINICAL JOURNAL OF GASTROENTEROLOGY. 2022. 15. 5. 876-880

ｍore...

Lectures and oral presentations (30)：

皮膚悪性腫瘍まるごとアップデート「基底細胞癌の切除マージンと関連するリスク因子について」
(第39回日本皮膚悪性腫瘍学会学術大会 2023)
全身の基底細胞癌において深部切除マージンの決定に寄与する因子に関する後方視的検討
(第38回日本皮膚外科学会総会・学術集会 2023)
耳介や前額・こめかみの皮膚悪性腫瘍に対する手術
(第122回日本皮膚科学会総会 2023)
ガイドラインに則った熱傷診療の要点
(第122回日本皮膚科学会総会 2023)
全身性強皮症の患者に生じた両耳介後部の紅色局面
(第39回日本皮膚病理組織学会 2023)

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page